COVID-19 has become a pandemic in the United States and worldwide. COVID-19-induced
coagulopathy (CIC) is commonly encountered at presentation manifested by considerable …

Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy
caused by antibodies to complexes of platelet factor 4 (PF4) and heparin. Pathogenic …

Key Clinical Points Heparin-Induced Thrombocytopenia Heparin-induced thrombocytopenia
(HIT) is characterized by a decrease in the platelet count of more than 50% from the highest …

Disseminated intravascular coagulation (DIC) is a systemic activation of the coagulation
system, which results in microvascular thrombosis and, simultaneously, potentially life …

Background Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse
drug reaction that can lead to devastating thromboembolic complications, including …

Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …

The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT).
Although widely used in clinical practice, its predictive value for HIT in diverse settings and …

Heparin-induced thrombocytopenia is a profoundly dangerous, potentially lethal,
immunologically mediated adverse drug reaction to unfractionated heparin or, less …

This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …

A 63-year-old man with coronary artery disease who has recently undergone bypass
surgery presents with dyspnea. Laboratory testing reveals a platelet count of 86,000 per …